Supplements in the Ozempic Age - Available Now
| | How are weight-loss drugs shaping the future of the supplement industry? | From GLP-1 drugs' role in lowering the national obesity rate to social media’s spotlight on Berberine, we're experiencing seismic shifts in the weight loss and blood sugar management markets. In the Supplements in the Ozempic Age Report, NBJ analyzes these influences and reveals what they mean for supplement brands today and in the years to come. |
|
|
|
This special report features: Consumer Research: What consumers want and need in nutrition before, during and after GLP-1 drugs. Signature NBJ Data: Sales and growth data for Weight Management and Blood Sugar Management with estimates through 2027. |
|
|
|
|